Skip to main content

Table 2 Clinical and epidemiologic variables by Recurrence Pattern

From: Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior

 

Recurrence Pattern

P value*

Entire Cohort

Liver

Lung

Tumor Differentiationa

 Well/well to moderate

1 (1%)

1 (2%)

P = 0.047

2 (1%)

 Moderate

60 (59%)

36 (77%)

96 (65%)

 Moderate- poorly/Poorly

40 (40%)

10 (21%)

50 (34%)

Tumor Stage

 Stage I

3 (3%)

P = 0.194

3 (2%)

 Stage IIA

23 (22%)

6 (13%)

29 (19%)

 Stage IIB

76 (75%)

41 (87%)

117 (79%)

Lymph Node Status

 Positive

76 (75%)

41 (87%)

P = 0.089

117 (79%)

 Negative

26 (25%)

6 (13%)

32 (21%)

Vascular Invasiona

 Positive

69 (68%)

34 (72%)

P = 0.703

103 (70%)

 Negative

32 (32%)

13 (28%)

45 (30%)

Perineural Invasion

 Present

90 (88%)

45 (96%)

P = 0.226

135 (91%)

 Absent

12 (12%)

2 (4%)

14 (9%)

Tumor Margin

 Negative

89 (87%)

36 (77%)

P = 0.148

125 (84%)

 Positive

13 (13%)

11 (23%)

24 (16%)

Tumor Location

 Head

84 (83%)

38 (81%)

P = 0.942

132 (82%)

 Body

7 (7%)

4 (8%)

11 (7%)

 Tail

11 (10%)

5 (11%)

16 (11%)

Alcohol Use

 None

56 (55%)

15 (32%)

P = 0.011

71 (56%)

 Social

29 (28%)

25 (53%)

54 (36%)

 Daily/heavy

17 (17%)

7 (15%)

24 (16%)

Smoking

 None

55 (54%)

23 (49%)

P = 0.60

78 (52%)

 Current/former

47 (46%)

24 (51%)

71 (48%)

  1. Note: *p-value was calculated using Fisher’s exact test, aTumor differentiation and vascular invasion data was missing for one patient in liver group